Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer - Top-Institutions - MDSpire

Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer

  • By

  • Hang Li

  • Qian Li

  • Xiaojing Tie

  • Feng Ji

  • LiNa Ma

  • Chunyan Ma

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Swedish Cancer Institute
    Swedish Cancer Institute

    Seattle, Washington

    Key Differentiators

    • Oncology

  • #4

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Oncology

  • #5

    Institut Curie
    Institut Curie

    Paris, Île-de-France

    Key Differentiators

    • Oncology

Original Source(s)

Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer

  • by Hang Li, Qian Li, Xiaojing Tie, Feng Ji, LiNa Ma, Chunyan Ma

  • May 28, 2026

Related Content

Mesh-free prepectoral breast reconstruction: a safe and effective alternative

Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling

Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin